Recombinant B7-H3 (Mirzotamab Biosimilar) antibody

Catalog No. ABIN7675998

The Human Monoclonal anti-B7-H3 (Mirzotamab Biosimilar) antibody is suitable to detect B7-H3 (Mirzotamab Biosimilar) in samples from Human. It has been validated for BLI, ELISA, FACS, Func and SPR.

Quick Overview for Recombinant B7-H3 (Mirzotamab Biosimilar) antibody (ABIN7675998)

Target: B7-H3 (Mirzotamab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: Un-conjugated

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details

Expression System: CHO Cells

Purpose: Anti-B7-H3 / CD276 Reference Antibody (mirzotamAb)

Characteristics: Anti-B7-H3 / CD276 Reference Antibody (mirzotamAb) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details

Target: B7-H3 (Mirzotamab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: Q5ZPR3